z-logo
open-access-imgOpen Access
A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
Author(s) -
Liu Yang,
Zhao Dawen
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.774
Subject(s) - mechanism (biology) , immune system , rna , medicine , action (physics) , computational biology , pleural effusion , mechanism of action , cancer research , bioinformatics , biology , immunology , gene , genetics , physics , quantum mechanics , in vitro
Clinical evidence indicates that the microenvironment in malignant pleural effusion (MPE) is immunologically cold, which impairs tumour immunosurveillance and antitumor immune response to immune checkpoint blockade (ICB). In a recent issue of Nature Nanotechnology , Liu et al. demonstrate a new nanotechnological approach to effectively mitigate the immune cold MPE and provide insights into its mechanism of action through single‐cell RNA‐sequencing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here